Guus A M S van Dongen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Top Venues

Cancer research

European journal of nuclear medicine and molecular imaging

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Joey A Muns, Erik Schooten, Rychon D J van Dasselaar, Yvet E Noordman, Kevin Adamzek, Arthur C Eibergen, Sebas D Pronk, Sagel Cali, Niels J Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M P van Bergen En Henegouwen, R Bart Takkenberg, Joanne Verheij, Stan F J van de Graaf, Bart A Nijmeijer, Guus A M S van Dongen
Preclinical targeting of liver fibrosis with a 89 Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β. European journal of nuclear medicine and molecular imaging (2024)
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E Sanborn, Randy F Sweis, Patricia LoRusso, Misako Nagasaka, Javier García Corbacho, Shadia Jalal, James J Harding, Stella K Kim, Iris H C Miedema, Danielle J Vugts, Marc C Huisman, Gerben J C Zwezerijnen, Guus A M S van Dongen, Catharina Willemien Menke-van der Houven van Oordt, Song Wang, Tam Dang, Ivan A Zein, Olga Vasiljeva, Susan K Lyman, Virginia Paton, Alison Hannah, Joyce F Liu
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Guus A M S van Dongen
Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses. Cancer research 81 (15) (2021)